Current Liabilities
Total Current Liabilities
Gilead Sciences Total Current Liabilities decreased by 19.8% to $9.48B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 23.2%, from $12.34B to $9.48B. Over 5 years (FY 2020 to FY 2025), Total Current Liabilities shows relatively stable performance with a 0.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 7, 2026
How to read this metric
A rising trend relative to current assets may indicate liquidity strain, while a stable trend suggests healthy working capital management.
Detailed definition
Total current liabilities represent the sum of all financial obligations due within one year, including accounts payable...
Peer comparison
Standard liquidity metric used across all sectors to compare short-term solvency.
Metric ID:
total_current_liabilitiesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.21B | $10.25B | $11.61B | $8.56B | $9.22B | $10.42B | $11.24B | $10.53B | $13.96B | $11.95B | $11.28B | $13.02B | $10.78B | $11.73B | $12B | $12.34B | $11.19B | $12.3B | $11.81B | $9.48B |
| QoQ Change | — | +0.3% | +13.3% | -26.3% | +7.7% | +13.0% | +7.8% | -6.3% | +32.6% | -14.5% | -5.6% | +15.4% | -17.2% | +8.8% | +2.4% | +2.8% | -9.4% | +9.9% | -3.9% | -19.8% |
| YoY Change | — | — | — | — | -9.7% | +1.7% | -3.2% | +23.0% | +51.5% | +14.6% | +0.4% | +23.6% | -22.8% | -1.8% | +6.4% | -5.2% | +3.8% | +4.9% | -1.6% | -23.2% |
Range$8.56B – $13.96B
CAGR-1.6%
Avg YoY Growth+3.9%
Median YoY Growth+1.1%
Current Streak2 quarters decline
Total Current Liabilities at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's total current liabilities?
- Gilead Sciences (GILD) reported total current liabilities of $9.48B in Q1 2026.
- How has Gilead Sciences's total current liabilities changed year-over-year?
- Gilead Sciences's total current liabilities decreased by 23.2% year-over-year, from $12.34B to $9.48B.
- What is the long-term trend for Gilead Sciences's total current liabilities?
- Over 5 years (2020 to 2025), Gilead Sciences's total current liabilities has grown at a 0.7% compound annual growth rate (CAGR), from $11.4B to $11.81B.
- What does total current liabilities mean?
- The total amount of debt and obligations the company must pay within one year.